Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Cephagenix Logo
Cephagenix Growth Score
87
CB Rank
96934
Heat Score
3
Cephagenix focuses on identifying and developing new, effective migraine therapies.
Founded
obfuscation
PrivateSeed Glostrup, Hovedstaden, Denmark cephagenix.com
Health Care
Health Diagnostics
Medical
Wellness
Overview

Cephagenix
Total Funding
obfuscation
Growth Score
87
Heat Score
3

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score87
-4 pts
in past quarter
Heat Score 3
-24 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Cephagenix

CB Rank
96934
Cephagenix focuses on identifying and developing new, effective migraine therapies.
Founded
obfuscation
PrivateSeed Glostrup, Hovedstaden, Denmark cephagenix.com
Health Care
Health Diagnostics
Medical
Wellness

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Legal Name Cephagenix ApS
Operating Status Active
Company Type For Profit
Founders  Jes Olesen
About the Company
Cephagenix focuses on identifying and developing new, effective migraine therapies.
Contact Email info@cephagenix.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

Kir6.1/SUR2B K ATP Channel Inhibitors
Pharmaceutical compounds targeting the Kir6.1/SUR2B subtype of K ATP channels to inhibit their activity, aimed at treating migraine by preventing artery dilation linked to migraine attacks.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Cephagenix Logo
Seed Round - Cephagenix
2
obfuscation
AbbVie, AdBio partnersSeed
obfuscation
Seed Round - Cephagenix Logo
Seed Round - Cephagenix
2
obfuscation
AbbVie, AdBio partnersSeed
obfuscation
Seed Round - Cephagenix Logo
Seed Round - Cephagenix
2
obfuscation
AbbVie, AdBio partnersSeed
obfuscation
Seed Round - Cephagenix Logo
Seed Round - Cephagenix
2
obfuscation
AbbVie, AdBio partnersSeed
obfuscation
Seed Round - Cephagenix Logo
Seed Round - Cephagenix
2
obfuscation
AbbVie, AdBio partnersSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Cephagenix Logo
Seed Round - Cephagenix
2
obfuscation
AbbVie, AdBio partnersSeed
obfuscation
Seed Round - Cephagenix Logo
Seed Round - Cephagenix
2
obfuscation
AbbVie, AdBio partnersSeed
obfuscation
Seed Round - Cephagenix Logo
Seed Round - Cephagenix
2
obfuscation
AbbVie, AdBio partnersSeed
obfuscation
Seed Round - Cephagenix Logo
Seed Round - Cephagenix
2
obfuscation
AbbVie, AdBio partnersSeed
obfuscation
Seed Round - Cephagenix Logo
Seed Round - Cephagenix
2
obfuscation
AbbVie, AdBio partnersSeed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
AbbVie Logo
AbbVie
Yes
Seed Round - Cephagenix Logo
Seed Round - Cephagenix
—
AbbVie Logo
AbbVie
Yes
Seed Round - Cephagenix Logo
Seed Round - Cephagenix
—
AbbVie Logo
AbbVie
Yes
Seed Round - Cephagenix Logo
Seed Round - Cephagenix
—
AbbVie Logo
AbbVie
Yes
Seed Round - Cephagenix Logo
Seed Round - Cephagenix
—
AbbVie Logo
AbbVie
Yes
Seed Round - Cephagenix Logo
Seed Round - Cephagenix
—
Market Intelligence
People
View Profiles & Contacts
Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

215
74.8%
 in past month

IT Spend

$205.2KThis year, Cephagenix is projected to spend $205.2K on IT, according to Aberdeen.

Active Website Tech Count

2Cephagenix is actively using 2 technologies for its website, according to BuiltWith. These include Viewport Meta and  CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is Cephagenix's headquarters? Cephagenix is located in Glostrup, Hovedstaden, Denmark.Who invested in Cephagenix? Cephagenix has 2 investors including AbbVie and  AdBio partners.When was the last funding round for Cephagenix? Cephagenix closed its last funding round on
obfuscation
from a Seed round.Who are Cephagenix's competitors? Alternatives and possible competitors to Cephagenix may include Eli Lilly, AbbVie, and  Pfizer.How much funding has Cephagenix raised to date? Cephagenix has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3e39328 1)
|